期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Scar-centered dilation in the treatment of large keloids 被引量:3
1
作者 Min Wu Jie-Yu Gu +2 位作者 Ran Duan Bo-Xuan Wei Feng Xie 《World Journal of Clinical Cases》 SCIE 2022年第18期6032-6038,共7页
BACKGROUND Hypertrophic scars and keloid treatment is a major problem in plastic surgery.While small keloids can be treated with resection followed by radiotherapy,large keloids require treatment with a tissue expande... BACKGROUND Hypertrophic scars and keloid treatment is a major problem in plastic surgery.While small keloids can be treated with resection followed by radiotherapy,large keloids require treatment with a tissue expander.Conventional methods increase the need for auxiliary incisions,causing new scar hyperplasia.AIM To introduce a new method for the treatment of keloids with an expander.METHODS Between 2018 and 2021,we performed surgeries to treat large keloids in nine patients with a two-stage approach.In the first stage,an intrascar incision was made in the keloid,and a customized expander was implanted under the keloid and the surrounding normal skin.A period of 3-6 mo was allowed for skin expansion.In the second stage,after the initial incision healed,a follow-up surgery was performed to remove the expander,resect the keloid,and repair the expanded skin flap.To accomplish this,an incision was made along the scar boundary to avoid making a new surgical incision and creating new scars.Superficial radiotherapy was then performed postoperatively.RESULTS Two patients had anterior chest keloids.After treatment,the anterior chest incision was broken repeatedly and then sutured again after debridement.It healed smoothly without scar hyperplasia.Keloids were successfully removed in 7 patients without recurrence.CONCLUSION This method was performed through a keloid incision and with a custom expander embedded.After full expansion,the keloid was directly resected using a linear suture,which avoids new surgical incisions and scars and can successfully remove large-area keloids.The treatment is effective,providing new insights and strategies for the treatment of similar large-area keloid and hypertrophic scar cases in the future. 展开更多
关键词 EXPANDER KELOIDS Superficial radiotherapy intrascar incision TREATMENT
下载PDF
瘢痕内曲安奈德注射、超脉冲CO_(2)点阵激光及二者联合治疗老年增生性瘢痕的临床疗效对比研究 被引量:14
2
作者 林琳 刘维丽 +1 位作者 宣晓梅 王静 《临床和实验医学杂志》 2021年第18期2008-2011,共4页
目的对比瘢痕内曲安奈德(TA)注射、超脉冲CO_(2)点阵激光(UPCO_(2))及两者联合治疗老年增生性瘢痕(HS)的临床疗效。方法回顾性将2017年8月至2020年3月河北医科大学第一医院皮肤科收治的114例老年HS患者纳入本研究,根据不同治疗方式分为T... 目的对比瘢痕内曲安奈德(TA)注射、超脉冲CO_(2)点阵激光(UPCO_(2))及两者联合治疗老年增生性瘢痕(HS)的临床疗效。方法回顾性将2017年8月至2020年3月河北医科大学第一医院皮肤科收治的114例老年HS患者纳入本研究,根据不同治疗方式分为TA组、UPCO_(2)组和联合组,其中TA组患者接受瘢痕内TA注射治疗,UPCO_(2)组患者接受UPCO_(2)治疗,联合组患者接受瘢痕内TA注射联合UPCO_(2)治疗。比较3组的临床疗效,治疗前后温哥华瘢痕量表(VSS)、视觉模拟疼痛量表(VAS)、瘙痒评分变化情况,治疗结束后6个月的不良反应发生率和复发率,以及总的治疗费用。结果联合组的临床总有效率(96.97%)比TA组(75.00%)和UPCO_(2)组(77.78%)高,差异有统计学意义(P<0.05)。治疗结束后,联合组VSS、VAS和瘙痒评分分别为(4.05±1.24)、(3.00±0.62)、(2.02±0.51)分,均低于TA组[(5.57±1.39)、(3.98±0.74)、(3.09±0.55)分]和UPCO_(2)组[(5.42±1.32)、(3.74±0.69)、(2.78±0.48)分],差异均有统计学意义(P<0.05)。联合组、TA组、UPCO 2组的不良反应发生率(6.25%vs 16.7%vs 11.1%)和复发率(3.13%vs 11.1%vs 8.89%)比较,差异均无统计学意义(P>0.05);联合组治疗总费用为(6784.3±485.2)元,均高于TA组(4352.8±432.3)元和UPCO_(2)组(5534.8±525.6)元,差异均有统计学意义(P<0.05)。结论瘢痕内TA注射联合超脉冲CO_(2)点阵激光治疗老年HS疗效良好,可显著改善临床症状,安全性好,复发率低。 展开更多
关键词 增生性瘢痕 瘢痕内注射 超脉冲CO_(2)点阵激光 联合
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部